Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
Recce, an Australian biotechnology company, has successfully obtained a patent in Vietnam. This development marks a strategic expansion of Recce's intellectual property rights within the Southeast Asian market, reinforcing its innovation protection and commercial positioning in the region.
Recce Pharmaceuticals has obtained formal approval for its eighth Family 4 patent from Vietnam’s Intellectual Property Office, broadening its global intellectual property defenses for its anti-infective drug candidates. This newly granted patent, valid until 2041, covers manufacturing processes and administration meth…
Recce Pharmaceuticals has obtained a patent in Vietnam covering its R327 and R529 anti-infective drug candidates, extending protection through 2041. This marks the company’s eighth family 4 patent granted across major international markets. The move underscores Recce’s strategic focus on combating antibiotic resistanc…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.